Dr. Abbi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1501 S Madison St
Appleton, WI 54915Phone+1 920-884-3135Fax+1 920-884-3144
Education & Training
- University of ToledoFellowship, Hematology and Medical Oncology, 2011 - 2013
- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2008 - 2011
- Government Medical College AmritsarClass of 2004
Certifications & Licensure
- MI State Medical License 2020 - 2027
- WI State Medical License 2016 - 2025
- IA State Medical License 2014 - 2018
- OH State Medical License 2011 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 32 citationsCladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphomaStephen E. Spurgeon, Talia Pindyck, Craig Okada, Yiyi Chen, Zunqiu Chen
Leukemia & Lymphoma. 2011-07-14 - 9 citationsPotential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.Kamal Kant Singh Abbi, Margarida Silverman, Umar Farooq, Annick Tricot, Lindsey Dozeman
British Journal of Haematology. 2016-08-01 - 9 citationsPhase I/II study of clofarabine, etoposide, and mitoxantrone in patients with refractory or relapsed acute leukemia.Kamal Kant Singh Abbi, Witold B. Rybka, W. Christopher Ehmann, David F. Claxton
Clinical Lymphoma, Myeloma & Leukemia. 2015-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: